Bicara Therapeutics Inc.

BCAX - Company ID 0002023658

Market cap$1.95 B

Rank#2160

Filings220

Bicara Therapeutics Inc. has filed 220 public company documents between 2024 and 2026. The most frequent type is insider trade (67 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchBCAX overview$1.95 BMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyRank #2160See the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with LLYPeer viewPut BCAX beside LLY across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow BCAX via RSS

Similar companies to research next

LLYEli Lilly and Company

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
CORRESP	Company correspondence	7mo ago2025-11-24	-	View filing
CORRESP	Company correspondence	1y ago2024-09-10	-	View filing
CORRESP	Company correspondence	1y ago2024-09-10	-	View filing
CORRESP	Company correspondence	1y ago2024-09-03	-	View filing
CORRESP	Company correspondence	1y ago2024-08-27	-	View filing
CORRESP	Company correspondence	1y ago2024-08-22	-	View filing

Bicara Therapeutics Inc.

Similar companies to research next

Year